These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16608026)

  • 1. Oral regimen consisting of UFT/UZEL for elderly patients with colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
    Hepatogastroenterology; 2006; 53(68):209-12. PubMed ID: 16608026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB
    J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
    Thongprasert S; Maoleekoonpairoj S; Laohavinij S; Thavichaigarn P
    J Med Assoc Thai; 2000 Jun; 83(6):676-80. PubMed ID: 10932496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.
    Scalamogna R; Brugnatelli S; Tinelli C; Sagrada P; Gattoni E; Tronconi MC; Riccardi A; Luchena G; Corazza GR
    Oncology; 2007; 72(5-6):267-73. PubMed ID: 18187947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients.
    Somali I; Meydan N; Tarhan MO; Oztop I; Alacacioglu A; Yilmaz U
    J BUON; 2009; 14(3):429-33. PubMed ID: 19810134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
    Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase I study of combination-therapy using personalized peptide vaccine and UFT/UZEL for advanced or recurrent colorectal cancer].
    Hattori T; Okuno K; Yoshida K; Kokubu T; Mine T; Yamada R; Itoh K; Shiozaki H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1745-7. PubMed ID: 17212094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of oral tegafur/uracil and leucovorin as a first line therapy for elderly patients with advanced or metastatic colorectal cancer.
    Murata K; Yamamoto H; Fukunaga M; Kato T; Ohnishi T; Uemura Y; Ohta H; Kimura F; Ohue M; Nezu R; Sekimoto M; Ikeda M; Mizushimaz T; Doki Y; Mori M;
    Hepatogastroenterology; 2014; 61(129):94-8. PubMed ID: 24895801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer.
    Mizushima T; Tamagawa H; Matsuda C; Murata K; Fukunaga M; Ota H; Hasegawa J; Tsujie M; Fukuzaki T; Hata T; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Oncology; 2015; 89(3):152-8. PubMed ID: 25967649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.